SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 22 9 2020
medline: 2 1 2021
entrez: 21 9 2020
Statut: ppublish

Résumé

To estimate seroprevalence of severe acute respiratory syndrome 2 (SARS-CoV-2) among healthcare, first response, and public safety personnel, antibody testing was conducted in emergency medical service agencies and 27 hospitals in the Detroit, Michigan, USA, metropolitan area during May-June 2020. Of 16,403 participants, 6.9% had SARS-CoV-2 antibodies. In adjusted analyses, seropositivity was associated with exposure to SARS-CoV-2-positive household members (adjusted odds ratio [aOR] 6.18, 95% CI 4.81-7.93) and working within 15 km of Detroit (aOR 5.60, 95% CI 3.98-7.89). Nurse assistants (aOR 1.88, 95% CI 1.24-2.83) and nurses (aOR 1.52, 95% CI 1.18-1.95) had higher likelihood of seropositivity than physicians. Working in a hospital emergency department increased the likelihood of seropositivity (aOR 1.16, 95% CI 1.002-1.35). Consistently using N95 respirators (aOR 0.83, 95% CI 0.72-0.95) and surgical facemasks (aOR 0.86, 95% CI 0.75-0.98) decreased the likelihood of seropositivity.

Identifiants

pubmed: 32956614
doi: 10.3201/eid2612.203764
pmc: PMC7706918
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2863-2871

Références

J Microbiol Immunol Infect. 2021 Feb;54(1):54-60
pubmed: 32359943
Emerg Infect Dis. 2020 Sep;26(9):1978-1986
pubmed: 32544053
JAMA. 2020 Jun 16;323(23):2425-2427
pubmed: 32421144
JAMA Intern Med. 2020 Jul 21;:
pubmed: 32692365
Infect Control Hosp Epidemiol. 2020 Jul;41(7):765-771
pubmed: 32391746
BMC Health Serv Res. 2009 Jun 29;9:110
pubmed: 19563625
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Clin Virol. 2020 Jul;128:104437
pubmed: 32434708
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
Pediatr Allergy Immunol. 2020 Oct;31(7):841-847
pubmed: 32413201
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1122-1126
pubmed: 32817602
Am J Infect Control. 2017 May 1;45(5):542-543
pubmed: 28302435
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Nat Med. 2020 Aug;26(8):1193-1195
pubmed: 32504052
Ann Epidemiol. 2020 Aug;48:23-29.e4
pubmed: 32648546
Emerg Infect Dis. 2020 Nov;26(11):2766-2769
pubmed: 32731911
Clin Infect Dis. 2020 Dec 17;71(10):2702-2707
pubmed: 32548613
Clin Infect Dis. 2020 Dec 17;71(10):2688-2694
pubmed: 32497196
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Health Aff (Millwood). 2020 Sep;39(9):1624-1632
pubmed: 32663045

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH